MA54376A - Formulation pour l'administration d'un médicament pour le côlon - Google Patents

Formulation pour l'administration d'un médicament pour le côlon

Info

Publication number
MA54376A
MA54376A MA054376A MA54376A MA54376A MA 54376 A MA54376 A MA 54376A MA 054376 A MA054376 A MA 054376A MA 54376 A MA54376 A MA 54376A MA 54376 A MA54376 A MA 54376A
Authority
MA
Morocco
Prior art keywords
medication
colon
formulation
administration
Prior art date
Application number
MA054376A
Other languages
English (en)
Inventor
González Roberto Carlos Bravo
Felipe Varum
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of MA54376A publication Critical patent/MA54376A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
MA054376A 2018-12-07 2019-12-05 Formulation pour l'administration d'un médicament pour le côlon MA54376A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18211141.9A EP3662900A1 (fr) 2018-12-07 2018-12-07 Formulation d'administration de médicament colonique

Publications (1)

Publication Number Publication Date
MA54376A true MA54376A (fr) 2022-03-16

Family

ID=64661226

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054376A MA54376A (fr) 2018-12-07 2019-12-05 Formulation pour l'administration d'un médicament pour le côlon

Country Status (14)

Country Link
US (1) US20220016037A1 (fr)
EP (2) EP3662900A1 (fr)
JP (1) JP7423629B2 (fr)
KR (1) KR102777246B1 (fr)
CN (1) CN113164400A (fr)
AR (1) AR117281A1 (fr)
AU (1) AU2019394740B2 (fr)
BR (1) BR112021010913A2 (fr)
CA (1) CA3122033A1 (fr)
EA (1) EA202191431A1 (fr)
IL (1) IL283719B1 (fr)
MA (1) MA54376A (fr)
TW (1) TWI837237B (fr)
WO (1) WO2020115257A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2994844T3 (en) * 2018-12-07 2025-02-03 Tillotts Pharma Ag Colonic drug delivery formulation
EP3662901B1 (fr) 2018-12-07 2025-01-01 Tillotts Pharma AG Formulation de médicaments à une liberation ralentie avec une couche extérieure comprenant un polymère dégradable par des enzymes, sa composition et son processus de production

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812490D0 (en) 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
US5422121A (en) 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
US5656290A (en) 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
GB9722426D0 (en) 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
GB9724186D0 (en) 1997-11-14 1998-01-14 British Tech Group Low temperature coatings
FI20000780A7 (fi) 2000-04-03 2001-10-04 Novasso Oy Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
GB2367002A (en) 2000-09-25 2002-03-27 British Sugar Plc Coating composition
GB0203421D0 (en) 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US7670627B2 (en) 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
DE102005032806A1 (de) 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
US8998802B2 (en) * 2006-05-24 2015-04-07 Olympus Medical Systems Corp. Endoscope, endoscopic apparatus, and examination method using endoscope
DK2152250T3 (da) 2007-05-07 2019-12-09 Evonik Degussa Gmbh Faste doseringsformer, der omfatter et enterisk overtræk, med accelereret lægemiddelfrigivelse
AU2012230733B2 (en) * 2011-03-23 2016-10-20 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
HRP20192210T1 (hr) * 2012-04-30 2020-02-21 Tillotts Pharma Ag Formulacija lijeka s produženim otpuštanjem
EP3187171B1 (fr) * 2012-04-30 2024-09-25 Tillotts Pharma AG Formulation de médicament à libération retardée
US10799515B2 (en) * 2013-10-29 2020-10-13 Tillotts Pharma Ag Delayed release drug formulation
ES2874669T3 (es) 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
CN109562147B (zh) 2016-06-28 2023-09-01 特里瓦生物制剂有限公司 保护微生物组免受口服抗生素

Also Published As

Publication number Publication date
EP3890711A1 (fr) 2021-10-13
EP3662900A1 (fr) 2020-06-10
KR102777246B1 (ko) 2025-03-07
IL283719B1 (en) 2026-04-01
CN113164400A (zh) 2021-07-23
AU2019394740A1 (en) 2021-06-17
TWI837237B (zh) 2024-04-01
CA3122033A1 (fr) 2020-06-11
US20220016037A1 (en) 2022-01-20
AR117281A1 (es) 2021-07-28
BR112021010913A2 (pt) 2021-08-24
IL283719A (en) 2021-07-29
EA202191431A1 (ru) 2021-09-13
WO2020115257A1 (fr) 2020-06-11
TW202038916A (zh) 2020-11-01
JP2022515340A (ja) 2022-02-18
AU2019394740B2 (en) 2025-02-27
KR20210100666A (ko) 2021-08-17
JP7423629B2 (ja) 2024-01-29

Similar Documents

Publication Publication Date Title
EP3621656A4 (fr) Formulation pour l'administration d'un médicament pour les yeux
EP3826589A4 (fr) Dispositif ophtalmique pour l'administration de médicaments
EP3740272A4 (fr) Orifice d'injection pour administration thérapeutique
MA51617A (fr) Mécanisme d'administration de médicament
MA53858A (fr) Réplicons à base d'alphavirus pour l'administration d'agents biothérapeutiques
MA50557A (fr) Pistons pour dispositifs d'administration de médicament
EP3813853A4 (fr) Compositions pour l'administration de médicaments et leurs méthodes d'utilisation
EP3509573A4 (fr) Compositions pharmaceutiques pour l'administration d'un peptide
EP3694413A4 (fr) Réduction de dose de contraste pour imagerie médicale à l'aide d'un apprentissage profond
EP3606922A4 (fr) Conjugaison d'un médicament cytotoxique avec une bis-liaison
MA53375A (fr) Dispositifs d'administration pour l'administration de médicaments
EP3793680C0 (fr) Dispositif d'administration de radio-embolisation
EP3377009A4 (fr) Structures poreuses pour dispositifs d'administration de médicament à libération prolongée
EP3310343A4 (fr) Compositions implantables pour administration de médicaments et méthodes d'utilisation desdites compositions
EP3442503A4 (fr) Composition injectable pour l'administration d'un agent biologiquement actif
EP3481465A4 (fr) Ensemble d'administration de médicament pour médicaments sous forme de cartouches
EP3852655A4 (fr) Dispositifs d'exosquelette extensibles pour administration de médicaments
EP4007564A4 (fr) Administration intracrânienne d'une solution médicamenteuse
EP3523274A4 (fr) Formulations pour l'administration d'eflornithine
EP3836866A4 (fr) Systèmes d'administration entérique d'agents thérapeutiques
EP3643353A4 (fr) Robot d'administration de médicament
EP3672665A4 (fr) Exostructure d'assistance pour injection précise avec une seringue
EP3498280A4 (fr) Administration et dosage d'un agent thérapeutique pour l'endométriose
EP3664867A4 (fr) Accessoire de communication pour un dispositif d'administration de médicament
EP3503873A4 (fr) Compositions ophtalmiques à base d'épinéphrine pour administration intraoculaire et leurs procédés de production